Template:Cefuroxime: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 25: | Line 25: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime compatibility and stability |Compatibility and Stability ]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime compatibility and stability |Compatibility and Stability ]] | ||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime direction for use|Direction For Use]] | |||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Cefuroxime labels and packages|Labels and Packages]] | ||
|- | |- | ||
|} | |} | ||
Revision as of 05:14, 5 January 2014
| Cefuroxime |
|---|
| CEFUROXIME®,ZINACEF®,KEFUROX® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Compatibility and Stability |
| Direction For Use |
| Labels and Packages |